Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation

被引：0

作者：

Takenaka, Katsuto ^{[1
]}

Fuji, Shigeo ^{[2
]}

Matsukawa, Toshihiro ^{[3
]}

Uchida, Naoyuki ^{[4
]}

Kobayashi, Takeshi ^{[5
]}

Tanaka, Masatsugu ^{[6
]}

Ara, Takahide ^{[7
,8
]}

Ikegame, Kazuhiro ^{[9
]}

Ozawa, Yukiyasu ^{[10
]}

Kanda, Yoshinobu ^{[11
]}

Sawa, Masashi ^{[12
]}

Maruyama, Yumiko ^{[13
]}

Fukuda, Takahiro ^{[14
]}

Nakamae, Hirohisa ^{[15
]}

Kimura, Takafumi ^{[16
]}

Ogata, Masao ^{[17
]}

Seo, Sachiko ^{[18
]}

Atsuta, Yoshiko ^{[19
,20
]}

Matsuo, Keitaro ^{[21
]}

Nakasone, Hideki ^{[22
]}

机构：

[1] Ehime Univ, Dept Hematol Clin Immunol & Infect Dis, Grad Sch Med, Toon, Japan

[2] Osaka Int Canc Ctr Inst, Osaka, Japan

[3] Hokkaido Univ, Dept Hematol, Fac Med, Sapporo, Hokkaido, Japan

[4] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan

[5] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan

[6] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa, Japan

[7] Hokkaido Univ, Dept Hematol, Fac Med, Sapporo, Hokkaido, Japan

[8] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan

[9] Hyogo Med Univ Hosp, Dept Hematol, Nishinomiya, Hyogo, Japan

[10] Nagoya Daiichi Hosp, Japanese Red Cross Aichi Med Ctr, Nagoya, Aichi, Japan

[11] Jichi Med Univ, Dept Med, Div Hematol, Shimotsuke, Tochigi, Japan

[12] Anjo Kosei Hosp, Dept Hematol & Oncol, Anjo, Aichi, Japan

[13] Univ Tsukuba Hosp, Dept Hematol, Tsukuba, Ibaraki, Japan

[14] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan

[15] Osaka Metropolitan Univ Hosp, Dept Hematol, Osaka, Japan

[16] Japanese Red Cross Kinki Block Blood Ctr, Preparat Dept, Osaka, Japan

[17] Oita Univ Hosp, Dept Hematol, Yufu City, Japan

[18] Dokkyo Med Univ, Dept Hematol & Oncol, Mibu, Tochigi, Japan

[19] Aichi Med Univ, Sch Med, Dept Registry Sci Transplant & Cellular Therapy, Nagakute, Aichi, Japan

[20] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagakute, Aichi, Japan

[21] Aichi Canc Ctr Res Inst, Div Mol Med, Nagoya, Aichi, Japan

[22] Jichi Med Univ, Div Hematol, Saitama Med Ctr, Saitama, Japan

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180906

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[21] Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience
Desai, Nihar
Pasic, Ivan
Law, Arjun D.
Lam, Wilson
Gerbitz, Armin
Viswabandya, Auro
Kim, Dennis D.
Kumar, Rajat
Mattsson, Jonas
Novitzky-Basso, Igor
Michelis, Fotios V.
EUROPEAN JOURNAL OF HAEMATOLOGY, 2024,
[22] Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
Chemaly, Roy F.
Ullmann, Andrew J.
Stoelben, Susanne
Richard, Marie Paule
Bornhaeuser, Martin
Groth, Christoph
Einsele, Hermann
Silverman, Margarida
Mullane, Kathleen M.
Brown, Janice
Nowak, Horst
Koelling, Katrin
Stobernack, Hans P.
Lischka, Peter
Zimmermann, Holger
Ruebsamen-Schaeff, Helga
Champlin, Richard E.
Ehninger, Gerhard
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (19): : 1781 - 1789
[23] Letermovir for prophylaxis of cytomegalovirus in allogeneic hematopoietic stem cell recipients
Cho, J. C.
Le, A. D.
Locke, S. C.
DRUGS OF TODAY, 2018, 54 (06) : 361 - 368
[24] Letermovir prophylaxis for cytomegalovirus in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
Qingwei Wang
Minyuan Liu
Senlin Zhang
Li Gao
Xinran Chu
Bohan Li
Shengqin Cheng
Yuanyuan Tian
Yongping Zhang
Yixin Hu
Jie Li
Jun Lu
Peifang Xiao
Hu Liu
Shaoyan Hu
Bone Marrow Transplantation, 2025, 60 (3) : 422 - 424
[25] Acute kidney injury within 100 days post allogeneic hematopoietic cell transplantation is associated with increased risk of post-transplant complications and poor transplant outcomes
Madsen, Kayla
Pelletier, Karyne
Cote, Gabrielle
Kitchlu, Abhijat
Chen, Shiyi
Mattsson, Jonas
Pasic, Ivan
BONE MARROW TRANSPLANTATION, 2022, 57 (09) : 1411 - 1420
[26] Acute kidney injury within 100 days post allogeneic hematopoietic cell transplantation is associated with increased risk of post-transplant complications and poor transplant outcomes
Kayla Madsen
Karyne Pelletier
Gabrielle Côté
Abhijat Kitchlu
Shiyi Chen
Jonas Mattsson
Ivan Pasic
Bone Marrow Transplantation, 2022, 57 : 1411 - 1420
[27] Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
Patrick Derigs
Aleksandar Radujkovic
Maria-Luisa Schubert
Paul Schnitzler
Tilman Schöning
Carsten Müller-Tidow
Ute Hegenbart
Stefan O. Schönland
Thomas Luft
Peter Dreger
Michael Schmitt
Annals of Hematology, 2021, 100 : 2087 - 2093
[28] Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
Derigs, Patrick
Radujkovic, Aleksandar
Schubert, Maria-Luisa
Schnitzler, Paul
Schoening, Tilman
Mueller-Tidow, Carsten
Hegenbart, Ute
Schoenland, Stefan O.
Luft, Thomas
Dreger, Peter
Schmitt, Michael
ANNALS OF HEMATOLOGY, 2021, 100 (08) : 2087 - 2093
[29] Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients
Hamadeh, Issam S.
Grunwald, Michael R.
Martin, Allison
Patel, Jai N.
Shillingburg, Alexandra
Kachur, Ekaterina
Cook, Allene
Karabinos, Allison
Ai, Jing
Knight, Thomas G.
Ragon, Brittany K.
Chojecki, Aleksander L.
Shah, Nilay A.
Sanikommu, Srinivasa R.
Avalos, Belinda R.
Copelan, Edward A.
Shahid, Zainab
BLOOD, 2020, 136
[30] The impact of pre-transplant valganciclovir on early cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
Wilhelm, Kaci
Chemaly, Roy
Saliba, Rima
Gulbis, Alison
Saunders, Ila
Cool, Rita
Ferguson, Jill
Westmoreland, Michael
Rondon, Gabriela
Kebriaei, Partow
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2014, 20 (04) : 257 - 262

← 1 2 3 4 5 →